2021-2022 Regular Session • US Congress Legislature
HB2435: Gluten in Medicine Disclosure Act of 2021
Legislative Summary
To amend the Federal Food, Drug, and Cosmetic Act to require the label of a drug that is intended for human use and contains an ingredient that is derived directly or indirectly from a gluten-containing grain to identify each such ingredient, and for other purposes.
Demographic Impact
Overall analysis of equity impact
90% Positive
High ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
4/8/2021
Introduced in House
House of Representatives
4/8/2021
Referred to the House Committee on Energy and Commerce.
House of Representatives
4/9/2021
Referred to the Subcommittee on Health.
House of Representatives
Status Information
Current Status
Introduced(4/8/2021)
Chamber
House of Representatives
Committee
Subcommittee on Health(House of Representatives)
Sponsors
Democrat: 25
Republican: 3
Primary Sponsor
Tim Ryan
Democrat
Co-Sponsors (27)
Steve Stivers
Republican
Chellie Pingree
Democrat
Ro Khanna
Democrat
Betty McCollum
Democrat
Cindy Axne
Democrat
Thomas Suozzi
Democrat
Madeleine Dean
Democrat
Steve Cohen
Democrat
Brian Fitzpatrick
Republican
Bill Foster
Democrat
Josh Harder
Democrat
Earl Blumenauer
Democrat
Julia Brownley
Democrat
Doris Matsui
Democrat
Bobby Rush
Democrat
David Trone
Democrat
Kurt Schrader
Democrat
Darren Soto
Democrat
Jim Cooper
Democrat
Ayanna Pressley
Democrat
Ted Lieu
Democrat
Conor Lamb
Democrat
John Katko
Republican
Kaialii Kahele
Democrat
Zoe Lofgren
Democrat
Elaine Luria
Democrat
Colin Allred
Democrat